Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Michele Moreau
Affiliation
ORCID
Career Start Year
1994
Papers
29
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37368273
Smart Radiotherapy Biomaterials for Image-Guided In Situ Cancer Vaccination.
2023
37242072
Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment.
2023
34530092
Boosting the Abscopal Effect Using Immunogenic Biomaterials With Varying Radiation Therapy Field Sizes.
Int J Radiat Oncol Biol Phys
2022
36776362
Phytoradiotherapy to enhance cancer treatment outcomes with cannabidiol, bitter melon juice, and plant hemoglobin.
2022
36620560
A liquid immunogenic fiducial eluter for image-guided radiotherapy.
Front Oncol
2022
34765538
Optimizing Vaccination During Radiotherapy.
Frontiers in Oncology
2021
33202903
Imaging and Characterization of Sustained Gadolinium Nanoparticle Release from Next Generation Radiotherapy Biomaterial.
Nanomaterials
2020
31991819
Characterization of Isolated Extracts from Plant Leaves used as Remedy for Anemia.
Molecules
2020
29594038
Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants.
Frontiers in Oncology
2018
30245691
Radiation and Local Anti-CD40 Generate an Effective Vaccine in Preclinical Models of Pancreatic Cancer.
Frontiers in Immunology
2018
29740535
Enhancing the Therapeutic Efficacy of Cancer Treatment With Cannabinoids.
Frontiers in Oncology
2018
28971063
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids.
Frontiers in Oncology
2017
27910826
Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.
Physics in Medicine and Biology
2016
26309064
Potential for enhancing external beam radiotherapy for lung cancer using high-Z nanoparticles administered via inhalation.
Physics in Medicine and Biology
2015
24774442
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
Journal of Sexual Medicine
2014
22248038
Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Journal of Sexual Medicine
2012
21244215
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia.
Climacteric
2011
20019375
Postmenopausal hormone therapy increases retinal blood flow and protects the retinal nerve fiber layer.
Investigative Ophthalmology and Visual Science
2010
20459349
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy.
Gynecological Endocrinology
2010
19424093
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Menopause
2009
19436225
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
Menopause
2009
19436226
Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
Menopause
2009
18987368
Testosterone for low libido in postmenopausal women not taking estrogen.
N Engl J Med
2008
16932240
Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Menopause
2006
15937609
Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.
Journal of Obstetrics and Gynaecology Canada
2005
12849799
Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
Fertility and Sterility
2003
12544674
Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study.
Menopause
2003
11343482
Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.
JAMA - Journal of the American Medical Association
2001
8203035
[Update on menopause].
1994
1 - 29 of 29
Column Actions
Search
Recommended Authors
Collaborators
Céline Bouchard
Co-authored papers
9
David F Archer
Co-authored papers
7
Susan R Davis
School of Public Health and Preventive Medicine, Monash University
Co-authored papers
2
Robin Kroll
Co-authored papers
2
Leonard R Derogatis
Co-authored papers
2
Susan R Davis
Co-authored papers
2
Arthur S Waldbaum
Co-authored papers
2
Cynthia Rodenberg
Co-authored papers
2
Alain Moufarege
Co-authored papers
1
Christine Derzko
Co-authored papers
1
Norman Kakos
Co-authored papers
1
Helga Koch
Co-authored papers
1
Curtiland Deville
Johns Hopkins University
Co-authored papers
1
Nick Panay
Co-authored papers
1
Jan L Shifren
Co-authored papers
1
Akshay Buch
Co-authored papers
1
Margery Gass
Co-authored papers
1
Glenn D Braunstein
Co-authored papers
1
Sheila O'Neill
Co-authored papers
1
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers
1
John Studd
Co-authored papers
1
Simon Pack
Co-authored papers
1
Patricia Bearnson
Co-authored papers
1
Angelica Lindén Hirschberg
Co-authored papers
1
Stephen B Levine
Co-authored papers
1
Molly Katz
Co-authored papers
1
David Kozono
Co-authored papers
1
Kathryn Wekselman
Co-authored papers
1
1 - 28